Medication Mismanagement in Older Australians Living Alone

Around 1.6 million older Australians live alone. For many of them, managing a complex medication regimen without daily support is one of the most quietly dangerous parts of their day. It does not look like a crisis from the outside. The house is tidy, the person seems well, and they say they are “managing fine.” But inside the bathroom cabinet, or on the kitchen bench, there may be six, eight, or twelve different medicines taken at different times, some with food, some without, some that must never be taken together.

The consequences are measurable and large. Medication-related problems cause an estimated 250,000 hospital admissions in Australia every year, at a cost of around $1.4 billion, and roughly two-thirds of those admissions are potentially preventable.^[1] Older people living alone carry a disproportionate share of that risk. This is not primarily about confusion or cognitive decline, though both matter. It is about a healthcare system that has historically prescribed in silos, discharged without adequate follow-up, and assumed that a patient who nods in a consulting room will remember everything once they get home.

The good news is that the 2024 to 2026 period has brought more reform to this area than any comparable window in recent decades. The difficult news is that those reforms are still bedding in, the workforce gaps remain real, and the older person at home is still often the last to benefit.

What Medication Mismanagement Actually Looks Like

“Polypharmacy” describes the use of five or more medicines concurrently, and it is extremely common in older Australians managing multiple chronic conditions. The problems that follow are not abstract. They include taking a morning dose twice because of a memory lapse, stopping a medicine without telling anyone because of side effects, taking a medicine prescribed years ago that no one has reviewed, or missing doses of a critical medicine because the repeat script ran out and transport to the chemist is difficult.

The risk concentrates at specific points. More than half of all medication errors occur at transitions of care, such as hospital discharge, and over 90 per cent of patients have at least one medication-related problem after leaving hospital.^[2] For an older person living alone, there is no partner checking whether the evening dose was taken, and no family member who notices that Mum seems more confused than usual and connects it to the new blood pressure tablet started three weeks ago. The system relies heavily on patients self-reporting problems, but many older Australians do not know what to report, or they minimise symptoms to avoid being a burden.

Therapists and nurses on the Home Visit Network regularly encounter situations where a client’s stated medication list does not match what is actually in the home, or where a community pharmacist and a specialist have both added medicines without the GP being immediately aware. These are not failures of individual clinicians. They are systemic failures of information flow.

The National Medicines Record: A Reform Worth Watching

One of the most consequential changes underway is the development of a National Medicines Record, which aims to consolidate accurate, up-to-date medicines information across all treating clinicians.^[3] Alongside this, prescribers are increasingly required to share medicines data by default through My Health Record, and pathology and imaging providers are being brought into a legal requirement to upload key results automatically, closing gaps that have long left community clinicians working from incomplete information.^[3]

This matters enormously for older people living alone. When a mobile nurse conducts a home visit and notices a potential interaction between two newly prescribed medicines, that information currently depends on a patchwork of records, recalled histories, and paper medication lists the patient may or may not have updated. A functioning National Medicines Record could give that nurse, and the patient’s GP, a single reliable source of truth.

The continued investment in a modernised My Health Record is a promising structural shift.^[3] But implementation reality is complicated. Not all GP practices, pharmacies, and hospital discharge systems are yet integrated smoothly. Data quality depends on every entry point working correctly. And for an older person with limited digital literacy, understanding what is in their record and how to correct errors may itself require assistance. The digital integration is only as useful as the human support surrounding it.

GP Access, Bulk Billing, and the Medication Review Gap

A meaningful medication review requires time and a trusted relationship between patient and GP. That relationship is under strain for many older Australians living alone, particularly where bulk billing availability has been patchy and out-of-pocket costs have discouraged frequent visits.

From 1 November 2025, bulk-billing incentives were extended to all Medicare-eligible patients, not only children and concession card holders as before. A new voluntary Bulk Billing Practice Incentive Program also pays practices an additional 12.5 per cent loading if they bulk bill every patient.^[4] The government has set a target of nine out of ten GP services being bulk billed by 2030. For an older person on a pension who has been spacing out GP visits to manage costs, this shift could change how often they seek review.

But the practical reality in 2025 and 2026 is mixed. Many urban practices, particularly in higher-cost areas, have not yet made the transition to full bulk billing. In regional and remote areas, workforce shortages mean the problem is not the cost of the appointment but whether a GP appointment is available at all. The policy is right. The implementation is uneven.

For complex medication management, a GP Chronic Condition Management Plan (GPCCMP), which replaced the former GP Management Plan and Team Care Arrangement on 1 July 2025, can facilitate referral to allied health professionals for up to five sessions per year. The referral uses a standard letter rather than a structured form, is valid for 18 months, and carries a rebate of around $61.80. A GP can also refer separately for a Home Medicines Review. For older people living alone who have multiple chronic conditions, ensuring a current GPCCMP is in place is one of the most practical steps a GP can take.

Home Medicines Reviews: Underused and Undersupported

A Home Medicines Review (HMR) involves an accredited pharmacist visiting the patient’s home to conduct a thorough assessment of all medicines, including over-the-counter preparations, supplements, and anything stored in bedside tables or bathroom cabinets. The pharmacist then provides a report to the GP, who can action changes. Since 2020 the program has also funded up to two follow-up visits within nine months of the initial review, allowing the pharmacist to check whether changes were actually implemented.^[5]

The clinical value is not in doubt. HMRs identify an average of three to four medicines-related problems per review, and among people receiving one, one in five is having an adverse medication reaction at the time of the visit.^[5] Yet the service remains significantly underutilised. Many GPs are uncertain when to refer. Many patients have never heard of the service. And because the visit requires an accredited pharmacist to travel to the home, and each provider is capped at 30 reviews per month, availability varies considerably by location.^[5]

For an older person living alone with polypharmacy, an HMR is not a nice-to-have. It is a clinical necessity. Mobile pharmacists and community nurses visiting the home are often the first clinicians to identify that a patient is taking medicines incorrectly, storing them at the wrong temperature, or using a dosage that was changed in hospital but never updated in the community. The therapists and nurses connected through the Home Visit Network report that discovering a discrepancy between the hospital discharge summary and what is actually on the kitchen bench is not unusual; it is, in their experience, routine.

Aged Care Reforms and What They Mean for Medication Safety at Home

The new rights-based Aged Care Act 2024 commenced on 1 November 2025, alongside the launch of the Support at Home program.^[6] For older Australians receiving funded in-home care, this represents a significant shift in both rights and services.

Critically, under Support at Home, clinical care carries zero participant co-contribution. This means nursing and allied health services, including physiotherapy, occupational therapy, podiatry, and speech pathology, are fully government funded with no co-contribution required regardless of the participant’s income or assets. For medication management, this means a registered nurse providing in-home medication support is accessible without cost barriers for eligible Support at Home participants. This is a detail that many families and carers do not yet know, and it matters enormously when deciding whether to ask for help.

The Strengthened Aged Care Quality Standards, also in force from 1 November 2025, now legally require providers to have systematic processes to identify, assess, manage, and review pain (Standard 5, Clinical Care).^[7] Pain that is poorly managed often drives inappropriate self-medication, or conversely, under-use of prescribed analgesia. Providers delivering in-home care to older Australians must now demonstrate that pain assessment is not an afterthought.

This sits within a broader policy direction of reducing financial barriers to essential care for older people remaining at home. From 1 October 2026, personal care services such as showering, dressing and continence support are scheduled to move into the fully funded clinical care category under Support at Home, removing co-contributions for those services as well (families should confirm the status of this change before treating it as settled).

Telehealth and the 12-Month Rule

Telehealth has been a lifeline for many older Australians living alone, particularly those with mobility limitations or who live in areas with limited GP availability. However, from 1 November 2025, Medicare telehealth rebates now require that the patient has had an in-person GP visit within the previous 12 months, or that they are enrolled in MyMedicare.^[4]

For older people who have been relying heavily on telehealth since COVID and who have not seen their GP in person for more than 12 months, this requirement may come as an unwelcome surprise. Practices should be proactively checking which patients are at risk of losing telehealth access and facilitating an in-person review where possible. For mobile healthcare providers visiting patients at home, this is also worth raising with clients who have not mentioned when they last physically attended a GP clinic.

Discharge, Transitions and the Highest-Risk Moment

Hospital discharge is the most dangerous moment in a medication journey for an older person living alone, which is unsurprising given that more than half of all medication errors occur at transitions of care.^[2] Medicines are added, doses are changed, previous medicines are sometimes stopped, and the patient is handed a printed discharge summary and sent home. If they are going home alone, there may be no one to help them reconcile that summary with what is already in the cabinet.

The Transition Care Program, restructured under the Aged Care Act 2024 from 1 November 2025, provides up to 12 weeks of support following hospital discharge, with home-based care typically commencing within 48 hours. For eligible participants, the Restorative Care Pathway (which replaced Short-Term Restorative Care) provides up to 16 weeks of support with a budget of around $6,000, or up to around $12,000 for eligible participants, classified as clinical care with zero co-contribution. Both are accessed through an assessment via the Single Assessment System, which replaced the former ACAT process in December 2024.

These programs create a window for medication reconciliation. A community nurse, pharmacist, or mobile allied health professional visiting in the first days after discharge can identify problems before they become crises. The tragedy is that not every older person discharged to home alone is assessed for, or offered, these programs in time.

What Families and Carers Can Do Right Now

If you are a family member or carer supporting an older person who lives alone, the most useful things you can do around medication safety are concrete and immediate.

First, ask the GP whether a Home Medicines Review is appropriate. If the person has multiple chronic conditions or has recently been in hospital, the answer is almost certainly yes. Second, check whether a GP Chronic Condition Management Plan (GPCCMP) is current, as this enables referral to allied health services. Third, ask the GP practice whether they have the person enrolled in MyMedicare, which protects telehealth access under the November 2025 rules.

If the person is already receiving Support at Home services, contact My Aged Care on 1800 200 422 to discuss whether nursing support for medication management can be added as clinical care with zero co-contribution. If you are a carer under stress, Carer Gateway on 1800 422 737 provides practical support and can help you think through the broader care picture.

A System Getting Better, But Not Fast Enough

The National Medicines Record, the modernised My Health Record, the GPCCMP, expanded bulk billing, and Support at Home’s zero co-contribution clinical care are all genuine improvements. The policy architecture for better medication safety in older Australians living alone is more coherent now than it has ever been.

But policy architecture is not the same as lived experience. The older person taking 11 medicines alone in a house in regional Victoria does not yet benefit from a National Medicines Record that is still being built. The GP who might refer them for an HMR is running a full appointment book and may not have time to identify that the referral is overdue. The mobile pharmacist who could visit them may have a waiting list.

The crisis is quiet because no one collapses dramatically. Instead, a medicine interaction causes a fall. A missed dose leads to an avoidable hospital admission. A preventable adverse event fills a public hospital bed, one of the 250,000 medication-related admissions Australia records each year.^[1] Understanding the reforms that exist and the gaps that remain is the first step toward closing the distance between what the system promises and what actually reaches the person at home.

Frequently Asked Questions

What is a Home Medicines Review and who can get one?

A Home Medicines Review (HMR) is a Medicare-funded service where an accredited community pharmacist visits your home to conduct a thorough review of all your medicines, including non-prescription and complementary medicines. It requires a referral from your GP, includes up to two follow-up visits within nine months, and is suitable for anyone managing multiple medicines or complex health conditions.

Has the GP Management Plan been replaced?

Yes. From 1 July 2025, the GP Management Plan and Team Care Arrangement were replaced by the GP Chronic Condition Management Plan (GPCCMP). It allows up to five allied health sessions per year, uses a standard referral letter rather than a structured form, and the referral is valid for 18 months.

Can I access nursing support for medication management through Support at Home?

Yes. Nursing is classified as clinical care under Support at Home and carries zero co-contribution for eligible participants, regardless of income or assets. Contact My Aged Care on 1800 200 422 to discuss your options.

What is the November 2025 telehealth change and does it affect older people?

From 1 November 2025, Medicare telehealth rebates require that the patient has had an in-person GP visit within the previous 12 months or is enrolled in MyMedicare. If an older person has not attended a GP clinic in person recently, they may lose access to bulk-billed telehealth consultations unless they enrol in MyMedicare or attend an in-person visit.

What is the National Medicines Record?

The National Medicines Record is a planned digital record consolidating up-to-date medicines information across all treating clinicians, with prescribers required to share medicines data via My Health Record by default. It is still being developed and rolled out as of mid-2026.

What support is available after a hospital discharge for an older person living alone?

The Transition Care Program provides up to 12 weeks of support following hospital discharge, with home-based care usually starting within 48 hours. The Restorative Care Pathway offers up to 16 weeks of reablement support classified as clinical care with zero co-contribution. Both require assessment through the Single Assessment System.

References

1. Pharmaceutical Society of Australia. Medicine Safety: Take Care (250,000 medication-related hospital admissions per year; ~$1.4 billion; at least half preventable). See also Lim R et al., Drug Safety, 2022 (two-thirds potentially preventable).
2. Australian Commission on Safety and Quality in Health Care. National Effort to Cut Medicine Errors at Transitions of Care (over 50% of medication errors occur at transitions; >90% of patients have a medication-related problem post-discharge).
3. Australian Government Department of Health, Disability and Ageing. Modernising My Health Record and National Medicines Record (medicines data sharing by default; pathology and imaging upload requirements).
4. Australian Medical Association. Changes to Bulk Billing Incentives in General Practice (effective 1 November 2025; 90% bulk billing target by 2030). Telehealth eligibility from 1 November 2025 per Department of Health.
5. Pharmacy Programs Administrator. Home Medicines Review Program ($222 per initial review as at July 2024; up to 30 per month; up to two follow-ups within nine months; average 3–4 problems identified per review).
6. Australian Government Department of Health, Disability and Ageing. About the New Rights-Based Aged Care Act 2024. Commenced 1 November 2025.
7. Aged Care Quality and Safety Commission. Safety of Clinical Care Services, Strengthened Quality Standard 5 (processes to identify and manage pain), effective 1 November 2025.